Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophy.


Journal

Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278

Informations de publication

Date de publication:
03 2022
Historique:
revised: 27 01 2022
received: 27 09 2021
accepted: 31 01 2022
pubmed: 23 2 2022
medline: 4 5 2022
entrez: 22 2 2022
Statut: ppublish

Résumé

Fatigue is a common and burdensome symptom of spinal muscular atrophy. Given its complex interactions, different dimensions of fatigue need to be investigated. The Multidimensional Fatigue Inventory is a widely used instrument that captures five distinct dimensions. The aim of this study was to investigate the validity and reliability of the German Multidimensional Fatigue Inventory in spinal muscular atrophy and to evaluate the presence of clinically relevant fatigue. One hundred and forty adult spinal muscular atrophy patients completed the Multidimensional Fatigue Inventory in a nationwide, multicenter, cross-sectional study. Structural validity was explored using principal component analysis. Cronbach's α was calculated to evaluate internal consistency. Convergent validity was assessed by correlation with a Visual Analog Scale for fatigue and the EuroQol-Five Dimension-Five Level Scale as a measure of quality of life. The original five-component model of the questionnaire constituted an acceptable fit. Internal consistency and convergent validity of general, physical, mental fatigue, and reduced activity were good. We observed a floor effect for mental fatigue. While physical fatigue exceeded the cutoff for clinically relevant fatigue, all dimensions but reduced motivation correlated negatively with quality of life. Age, depression, and ≥4 copies of the survival motor neuron 2 gene were associated with higher general/physical fatigue; unemployed participants reported higher scores for reduced activity/motivation. The Multidimensional Fatigue Inventory is a valid and reliable instrument to assess different dimensions of fatigue in spinal muscular atrophy. Fatigue is a relevant problem in spinal muscular atrophy and its assessment should be incorporated into standard care.

Identifiants

pubmed: 35191616
doi: 10.1002/acn3.51520
pmc: PMC8935281
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

351-362

Informations de copyright

© 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

Orphanet J Rare Dis. 2018 Apr 23;13(1):61
pubmed: 29688860
J Pain Symptom Manage. 2009 Jan;37(1):107-28
pubmed: 19111779
J Neurol. 2020 Jan;267(1):36-44
pubmed: 31552549
Lancet Neurol. 2020 Apr;19(4):317-325
pubmed: 32199097
Qual Life Res. 2014 Jun;23(5):1479-88
pubmed: 24214178
Lancet. 2004 Mar 20;363(9413):978-88
pubmed: 15043967
Br J Cancer. 2011 Jul 26;105(3):445-51
pubmed: 21750551
Sci Rep. 2016 Dec 21;6(1):19
pubmed: 28442790
Ther Adv Neurol Disord. 2021 Mar 5;14:1756286421998902
pubmed: 33747131
Scand J Caring Sci. 2019 Jun;33(2):467-477
pubmed: 30664270
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Muscle Nerve. 2017 Jun;55(6):869-874
pubmed: 27701745
Brain Sci. 2020 Dec 23;11(1):
pubmed: 33374658
Onkologie. 2003 Apr;26(2):140-4
pubmed: 12771522
J Neuromuscul Dis. 2019;6(4):453-465
pubmed: 31594243
Neurology. 2013 Jan 22;80(4):409-16
pubmed: 23339207
Health Qual Life Outcomes. 2015 Feb 12;13:20
pubmed: 25879413
Qual Life Res. 1995 Aug;4(4):293-307
pubmed: 7550178
J Neuromuscul Dis. 2019;6(1):109-117
pubmed: 30562906
Parkinsonism Relat Disord. 2012 Jun;18(5):532-6
pubmed: 22361576
J Psychosom Res. 2004 Feb;56(2):157-70
pubmed: 15016573
Pain Res Manag. 2018 May 9;2018:3152142
pubmed: 29854037
J Neurol. 2020 Aug;267(8):2398-2407
pubmed: 32361837
Community Ment Health J. 2015 Apr;51(3):377-82
pubmed: 24972909
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Muscle Nerve. 2016 Nov;54(5):836-842
pubmed: 27015431
Acta Neurol Belg. 2013 Dec;113(4):411-4
pubmed: 23616230
J Rehabil Med. 2017 Mar 6;49(3):228-233
pubmed: 28150857
J Med Econ. 2017 May;20(5):493-502
pubmed: 28035846
Eur J Health Econ. 2019 Aug;20(6):933-944
pubmed: 31030292
J Psychosom Res. 1995 Apr;39(3):315-25
pubmed: 7636775
Acta Oncol. 2007;46(1):97-104
pubmed: 17438711
Behav Genet. 2002 Mar;32(2):153-61
pubmed: 12036113
Sci Rep. 2020 Jul 6;10(1):11069
pubmed: 32632203
Neurology. 2003 Jan 14;60(1):122-3
pubmed: 12525733
Neuromuscul Disord. 2007 Oct;17(9-10):693-7
pubmed: 17658255
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S263-86
pubmed: 22588750
Br J Cancer. 1996 Jan;73(2):241-5
pubmed: 8546913
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
J Neurol. 2021 Mar;268(3):950-962
pubmed: 33029682

Auteurs

Camilla Binz (C)

Department of Neurology, Hannover Medical School, Hanover, Germany.

Alma Osmanovic (A)

Department of Neurology, Hannover Medical School, Hanover, Germany.
Essen Center for Rare Diseases (EZSE), University Hospital Essen, Essen, Germany.

Nele H Thomas (NH)

Department of Biometry, Hannover Medical School, Hanover, Germany.

Benjamin Stolte (B)

Department of Neurology, University Hospital Essen, Essen, Germany.

Maren Freigang (M)

Department of Neurology, Technische Universität Dresden, Dresden, Germany.

Isabell Cordts (I)

Department of Neurology, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.

Ramona Griep (R)

Department of Neurology, Center for ALS, SMA and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Ambulanzpartner Soziotechnologie APST GmbH, Berlin, Germany.

Zeljko Uzelac (Z)

Department of Neurology, Ulm University, Ulm, Germany.

Claudia D Wurster (CD)

Department of Neurology, Ulm University, Ulm, Germany.

Christoph Kamm (C)

Translational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, Rostock, Germany.

Hannah A Siegler (HA)

Department of Neurology, Hannover Medical School, Hanover, Germany.

Gary Wieselmann (G)

Department of Neurology, Hannover Medical School, Hanover, Germany.

Andreas Hermann (A)

Translational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, Rostock, Germany.
German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Rostock, Germany.

Paul Lingor (P)

Department of Neurology, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.

Marcus Deschauer (M)

Department of Neurology, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.

Albert C Ludolph (AC)

Department of Neurology, Ulm University, Ulm, Germany.
German Center for Neurodegenerative Diseases (DZNE) Ulm, Ulm, Germany.

Thomas Meyer (T)

Department of Neurology, Center for ALS, SMA and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Ambulanzpartner Soziotechnologie APST GmbH, Berlin, Germany.

René Günther (R)

Department of Neurology, Technische Universität Dresden, Dresden, Germany.
German Center for Neurodegenerative Diseases (DZNE) Dresden, Dresden, Germany.

Tim Hagenacker (T)

Department of Neurology, University Hospital Essen, Essen, Germany.

Susanne Petri (S)

Department of Neurology, Hannover Medical School, Hanover, Germany.

Olivia Schreiber-Katz (O)

Department of Neurology, Hannover Medical School, Hanover, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH